|
| Back to Summit | Summit Program | Summit Issues |
| Why Attend The Summit? |
Confirmed Speakers & Moderators
The following are confirmed to date:
Confirmed Speakers (listed alphabetically)
- Paul Berg, PhD, Professor of Biochemistry, Stanford University; Nobel Laureate
- Steward Brand, Co-Chairman, The Long Now Foundation; Award-Winning Writer
- Brook Byers, Partner, Kleiner Perkins Caufield & Byers
- Charles Cantor, PhD, Director, Center for Advanced Biotechnology at Boston College; Co-Founder and CSO, Sequenom
- Arthur Caplan, PhD, Emmanuel and Robert Hart Professor of Bioethics, Director of the Center for Bioethics, University of Pennsylvania
- Francis Collins, MD, PhD, Director, National Human Genome Research Institute, NIH
- Mariana Cook, Photographer
- Idelle Datlof, Founder, Stem Cell Action Network; MS Patient
- Nathaniel David, PhD, Co-Founder, Achaogen and Syrrx
- John P. Donoghue, PhD, Professor of Neuroscience, Brown University; Co-Founder, Cyberkinetics
- Diane Dorman, Vice President, National Organization for Rare Disorders (NORD)
- Jill Eikenberry, Actor; former star of LA Law
- Jennifer Elisseeff, PhD, Assistant Professor, Department of Biomedical Engineering, John Hopkins University
- Jean-Francois Formela, MD, Senior Partner, Atlas Venture
- Frederick Frank, Vice Chairman, Lehman Brothers
- Florence Haseltine, MD, PhD, Director, Center for Population Research; NIH
- William Haseltine, PhD, former CEO, Human Genome Sciences
- Steve Holtzman, CEO and Co-Founder, Infinity Pharmaceuticals; Former Chief Business Officer, Millennium Pharmaceuticals
- Leroy Hood, MD, PhD, Co-Founder and President, Institute for Systems Biology; Former William Gates III Professor of Biomedical Sciences at the University of Washington
- William Hurlbut, MD, Consulting Professor, Stanford University Program in Human Biology; Member of President's Council on Bioethics
- Tom Kalil, Assistant to the Chancellor for Science and Technology, UC Berkeley; former science and technology advisor to Bill Clinton
- Jay Keasling, PhD, Professor, Department of Chemical Engineering, UC Berkeley; Director, UC BioStar Program
- Cynthia Kenyon, PhD, Herbert Boyer Distinguished Professor of Biochemistry and Biophysics, University of California, San Francisco
- Caroline A. Kovac, PhD, General Manager, IBM Healthcare and Life Sciences
- Ted Love, MD, CEO, Nuvelo
- David Magnus, PhD, Bioethicist, Stanford University Medical School, Department of Bioethics
- Stephen Petranek, Editor-in-Chief, Discover Magazine
- Peter Petre, Senior Editor-at-Large, Fortune Magazine
- George Rathmann, PhD, Chairman, Nuvelo
- James Reston, Jr, Author and Commentator
- Floyd Romesberg, PhD, Asst. Professor, Department of Chemistry, Scripps Research Institute
- Cynthia Schneider, PhD, Professor of Diplomacy, Director, Life Sciences and Society Initiative, Georgetown University; former Ambassador for the US to the Netherlands
- George Schreiner, MD, PhD, President, Scion
- Bernard Siegel, Executive Director, Genetics Policy Institute
- Greg Simon, President, Center for Accelerating Medical Solutions, Milken Institute; former Chief Domestic Advisor to Al Gore
- Chris Smith, Program Director, Magic Theatre of San Francisco
- Jonathan B. Spear, VP, Public Policy, Global Government Affairs, Amgen, Inc.
- Kari Stefansson, MD, CEO and Co-Founder, deCODE Genetics
- Bruce Sterling, science fiction writer and columnist
- Gregory Stock, PhD, Director, Program on Medicine, Technology and Society at UCLA's School of Medicine
- Michael Tucker, Actor; former star of LA Law
- Craig Venter, PhD, President, The J. Craig Venter Science Foundation, Center for the Advancement of Genomics
- Michael Werner, Biotechnology Industry Organization
- Howard Zucker, MD, Deputy Assistant Secretary of Health, HHS
Confirmed Moderators (listed alphabetically)
- Chris Anderson, Editor-in-Chief, Wired Magazine
- David Ewing Duncan, BioAgenda Founder and Editorial Director
- James Fallows, National Correspondent, The Atlantic Monthly
- Ken Goldberg, PhD, Professor, Industrial Engineering and Operations Research, UC Berkeley; Director, The Art, Technology, and Culture Colloquium, UC Berkeley
- David Hamilton, Staff Reporter, The Wall Street Journal
- Andrew Pollack, Biotechnology Reporter, The New Your Times
- Jason Pontin, Editor-in-Chief, MIT Technology Review, former Editor-in-Chief, Acumen Journal of Life Sciences and Red Herring
- Cynthia Robbins-Roth, PhD, Founder of BioVenture Publishing, Inc. and BioVenture Consultants; journalist and best-selling author of From Alchemy to IPO
|
